Exact Sciences
EXAS
#1831
Rank
A$14.38 B
Marketcap
$77.46
Share price
-0.50%
Change (1 day)
-19.79%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.36

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.49. In 2022 the company made an earnings per share (EPS) of -$5.57 a decrease over its 2021 EPS that were of -$5.44.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.36-57.67%
2022-$5.572.31%
2021-$5.44-37.09%
2020-$8.65674.65%
2019-$1.12-50.69%
2018-$2.2644%
2017-$1.57-39.39%
2016-$2.59-2.94%
2015-$2.6737.1%
2014-$1.9579.71%
2013-$1.09-21.59%
2012-$1.3862.96%
2011-$0.8592.86%
2010-$0.44-3.45%
2009-$0.46-19.44%
2008-$0.57-18.18%
2007-$0.69-10.2%
2006-$0.77-10.91%
2005-$0.86-24.66%
2004-$1.15-51.33%
2003-$2.36-7.41%
2002-$2.5511.72%
2001-$2.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.78 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.53-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.63-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$80.04 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.00-300.57%๐Ÿ‡ซ๐Ÿ‡ท France